Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts from ‘June, 2009’

Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development

Appointment Consolidates Leadership of Vascular Intervention and Lead Management Businesses COLORADO SPRINGS, Colo.–(HSMN NewsFeed)–Spectranetics Corporation (Nasdaq:SPNC ) today announced the appointment of Jason Hein to the job of Senior Vice P…
Devices, Personnel
Spectranetics

Quick-Med Technologies Announces First Commercial Revenue of NIMBUS(R) Wound Care Products

New Quick-Med Wound Care Technology Now Available to $14 Billion Wound Care Market GAINESVILLE, Fla.–(HSMN NewsFeed)–Quick-Med Technologies, Inc. (OTCBB: QMDT ) announced today that Derma Sciences (OTCBB: DSCI ) has begun selling and shipping BIOGUARD…
Devices, Wound Care
Quick-Med Technologies, Derma Sciences, BIOGUARD, NIMBUS

Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO

NATICK, Mass., June 25 (HSMN NewsFeed) — Boston Scientific Corporation (NYSE: BSX ) announced today that President and Chief Executive Officer (CEO) Jim Tobin will retire from the Company, and that its board of directors has appointed Ray Elliott the ne…
Devices, Cardiology, Personnel
Boston Scientific

Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors

New Data from a Phase 3 Trial Presented NEW YORK–(HSMN NewsFeed)–Pfizer today announced results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic islet cell tumors, also known as pancreatic neuroendocrin…
Biopharmaceuticals, Oncology
Pfizer, Sutent, sunitinib malate, pancreatic islet cell tumor

Acclarent, Inc. Completes Office-Based Study Using Balloon Sinuplasty(TM) Technology

MENLO PARK, Calif., June 25 (HSMN NewsFeed) — Acclarent, Inc., a leading medical technology company dedicated to designing, developing, and commercializing products that address conditions affecting the ear, nose and throat (ENT) today announced the com…
Devices
Acclarent, Balloon Sinuplasty

SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Spain

SAN DIEGO, June 24 (HSMN NewsFeed) — SpectraScience, Inc. (OTC Bulletin Board: SCIE ), a San Diego based medical device company, today announced that it has established a distribution partnership in the Spanish market through SIM, a Madrid based firm sp…
Devices, Oncology, Distribution
SpectraScience, WavSTAT, Optical Biopsy, spectrophotometry

Dynatronics Begins Shipping New V-Force Vibration Therapy Units

SALT LAKE TOWN, June 24 (HSMN NewsFeed) — Dynatronics Corporation (Nasdaq: DYNT ) announced it has begun shipping its new V-Force Vibration Therapy units to customers. These new units employ powerful, whole-body vibration technology, which provides neur…
Devices
Dynatronics, V-Force, Vibration Therapy

Highway 12 Ventures Leads $10.3M Series D Financing of SynCardia, Manufacturer of World’s Only FDA-Approved Total Artificial Heart

Capital Will Help Fund Two New Driver Systems to Quadruple Patient Implant and Discharge Capacity TUCSON, Ariz.–(HSMN NewsFeed)–SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest(TM) Total Artificial Heart, today announced tha…
Devices, Cardiology, Venture Capital
SynCardia Systems, CardioWest, Artificial Heart

Abiomed Announces First FDA-Approved AbioCor(R) Implant at UMDNJ-Robert Wood Johnson Lab School and Robert Wood Johnson University Hospital

End-Stage Heart Failure Patient Receives AbioCor; Recovering Well Post-Surgery DANVERS, Mass.–(HSMN NewsFeed)–Abiomed, Inc. (NASDAQ: ABMD ), today announced the successful implant of its AbioCor(R) Total Replacement Heart, performed at Robert Wood Joh…
Devices, Cardiology
Abiomed, AbioCor, Total Replacement Heart, artificial heart

Medtronic Announces 2 Worldwide Clinical Trials to Study Clinical Device Interventions for Stroke

Trial Uses Reveal XT Insertable Cardiac Monitor to Assess Incidence of Atrial Fibrillation in Patients Who Have Suffered a Stroke of Unknown Origin Separate Trial to Compare Intrathecal Baclofen Therapy to Conventional Treatments in the Management of Se…
Devices, Monitoring, Cardiology, Neurology
Medtronic, Atrial Fibrillation, Insertable Cardiac Monitor, Intrathecal Baclofen